systematic-review-finds-residual-sars-cov-2-material-without-confirmed-infectious-virus
Systematic Review Finds Residual SARS-CoV-2 Material Without Confirmed Infectious Virus

Systematic Review Finds Residual SARS-CoV-2 Material Without Confirmed Infectious Virus

A systematic review evaluating biological evidence in individuals following SARS-CoV-2 infection found that viral genomic RNA, viral proteins, and markers compatible with recent viral activity were documented across selected tissue and blood compartments, yet no included investigation demonstrated replication competence through the recovery of infectious virus. The findings synthesize published research on viral persistence, immune activation, and histopathological alterations across diverse organ systems in post-acute infection settings.

Long COVID, also designated as post-acute sequelae of SARS-CoV-2, is estimated to affect approximately 10 to 20 percent of individuals after initial viral infection. While the condition imposes a substantial global health burden, its underlying pathophysiological mechanisms remain incompletely understood. To evaluate how viral remnants and host responses contribute to persistent illness, the researchers synthesized observations from symptom-defined post-acute patients alongside wider post-acute cohorts, autopsy series, and case investigations.

The research was conducted under PRISMA guidelines and registered with PROSPERO under registration code CRD420261403869. Investigators systematically searched four major electronic databases, specifically PubMed, Scopus, EMBASE, and Cochrane CENTRAL. Eligible publications were subsequently categorized into four distinct methodological strata: symptom-defined Long COVID evaluated at or beyond 12 weeks, broader post-acute or mixed patient groups lacking consistent diagnostic timing, dedicated autopsy investigations, and isolated case or fetal reports.

Across the surveyed literature, 45 individual reports met the criteria for inclusion in the narrative synthesis. Among these, 16 reports analyzed symptom-defined Long COVID at or after 12 weeks, 23 examined post-acute or mixed cohorts, three were autopsy investigations, and three documented isolated case or fetal presentations. Individual study quality was examined using Joanna Briggs Institute appraisal checklists to evaluate item-level characteristics rather than to assign definitive certainty-of-evidence grades.

The synthesized results demonstrated marked variability in the identification of viral components across anatomical sites. Detection of viral genomic sequences and viral proteins differed significantly based on participant selection criteria, post-infection sampling intervals, tissue specimen types, and specific analytical assays employed. The authors noted that a single aggregate participant total could not be determined across the review because of overlapping patient cohorts, repeated biospecimen sampling, and outcome-specific analytical denominators.

Histopathological assessments revealed structural and cellular abnormalities across evaluated tissues, characterized primarily by inflammatory infiltrates, fibrosis, and vascular injury. However, the systematic analysis determined that establishing clear causal attribution between these tissue changes and Long COVID was substantially constrained by several confounding elements. These limitations included acute illness severity, clinical indications driving tissue biopsies, underlying patient comorbidities, and the widespread absence of appropriate comparator groups.

Overall, the review supports notable biological heterogeneity following SARS-CoV-2 infection, encompassing persistent viral fragments, immune dysregulation, vascular injury, and maladaptive tissue repair pathways. Despite these observations, critical questions remain unanswered, as organ-specific prevalence, a distinct hierarchy of tissue tropism, replication-competent reservoirs, and the therapeutic superiority of antiviral or immunomodulatory regimens could not be established from the available evidence.

To resolve these lingering clinical and biological uncertainties, the authors concluded that future research requires standardized Long COVID diagnostic definitions alongside fully representative patient cohorts. Further investigation must also incorporate validated detection assays, properly matched control comparators, and longitudinal study designs capable of directly linking measurable biological markers with clinical health outcomes.

Subject of Research: Systematic review of viral persistence, immune activation, and histopathology in Long COVID

Article Title: Echoes of infection: viral persistence, immune activation, and histopathological changes in long COVID: a systematic review

Article References: Elmahroky, A., Aly, Y., Farghaly, A., Abdelrasoul, H., Suliman, H., Badawi, M., Tanbedawy, O. W., Helmy, A. E., & Nabeh, O. A. (2026). Echoes of infection: viral persistence, immune activation, and histopathological changes in long COVID: a systematic review. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-026-02339-5

Image Credits: AI Generated

DOI: 10.1007/s10238-026-02339-5

Keywords: Long COVID, post-acute sequelae of SARS-CoV-2, systematic review, SARS-CoV-2 RNA, viral persistence, immune activation, histopathology, vascular injury, tissue fibrosis, inflammatory infiltrates, autopsy studies, PRISMA guidelines, PROSPERO registration, viral proteins, replication competence, biological heterogeneity, JBI appraisal